[1]
A. Ahmad and M. Rehman, “COMPARATIVE EVALUATION OF INTRAVITREAL DICLOFENAC PLUS BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF NAÏVE DIABETIC MACULAR EDEMA: A RANDOMIZED CONTROLLED TRIAL”, Khyber Med Univ J, vol. 14, no. 4, pp. 228–33, Dec. 2022.